Related Experiment Video
Updated: May 13, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
The immunology of fibrosis
Georg Wick1, Cecilia Grundtman, Christina Mayerl
1Division of Experimental Pathophysiology and Immunology, 6020 Innsbruck, Austria. georg.wick@i-med.ac.at
Abstract:
Fibrosis is the production of excessive amounts of connective tissue, i.e., scar formation, in the course of reactive and reparative processes. Fibrosis develops as a consequence of various underlying diseases and presents a major diagnostically and therapeutically unsolved problem. In this review, we postulate that fibrosis is always a sequela of inflammatory processes and that the many different causes of fibrosis all channel into the same final stereotypical pathways. During the inflammatory phase, both innate and adaptive immune mechanisms are operative. This concept is exemplified by fibrotic diseases that develop as a consequence of tissue damage, primary inflammatory diseases, fibrotic alterations induced by foreign body implants, "spontaneous" fibrosis, and tumor-associated fibrotic changes.
Related Concept Videos
Introduction to Fibroblasts
Chronic Inflammation: Introduction
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction

